RxFunction, Inc.
StreetZero Signal 67
About RxFunction, Inc.
RxFunction, Inc. is a medical device company founded in 2010 with a mission to design and market technologies that improve balance, increase mobility, and enhance confidence for patients with peripheral neuropathy. Its flagship product, Walkasins Lower Limb Sensory Prosthesis, is a clinically proven wearable device that replaces lost nerve function in the feet to improve gait and reduce fall risk. The company is headquartered in Eden Prairie, Minnesota, and the technology originated from research at Boston University with initial NIH grant support.
LATEST FUNDINGPrivate Placement
$7.5M
Announced 2026-10-14
IN THE NEWS
- 🔗 [PDF] 5.3RxFunction Completes Series A Funding
- 🔗 RxFunction - 2026 Company Profile, Team, Funding & Competitors - Tracxn
- 🔗 RxFunction Stock Price, Funding, Valuation, Revenue & Financial Statements
- 🔗 RxFunction Seeking $12 Million in New Financing | Twin Cities Business
- 🔗 RxFunction Job Posting: Director of QA / RA
EMPLOYEES—
FOUNDED2010
HQEden Prairie, MN, United States
Industry
Manufacturing
Tags
Medical DeviceHealthcareWearables
Investors
Key highlights
- Raised $7.5M Series A in 2018 exceeding initial target to prepare for FDA registration and commercialization of Walkasins.
- Founded in 2010 by Dr. Lars Oddsson with initial NIH grant funding of $1.3M.
- Walkasins device is prescription-only and targets balance issues from peripheral neuropathy.
- Seeking additional financing of $12M as of 2019 to advance FDA approval.
Ask StreetZero about RxFunction, Inc.
Put our AI to work on this deal.
Similar companies
Other Manufacturing deals, ranked by Signal.
Source document & SEC filing
The source SEC filing and the cached document are available to members only. Sign in to view and download them.
Sign in to view the filing Create free account